Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology.
about
miRNAs as potential biomarkers in early breast cancer detection following mammographyEmerging role of cell polarity proteins in breast cancer progression and metastasisAtypical hyperplasia of the breast--risk assessment and management options.Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.The risk of upgrade for atypical ductal hyperplasia detected on magnetic resonance imaging-guided biopsy: a study of 100 cases from four academic institutionsClinicopathologic features of breast cancers that develop in women with previous benign breast disease.A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions.The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesionsTissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.Breast Dynamic Contrast Enhanced MRI: Fibrocystic Changes Presenting as a Non-mass Enhancement Mimicking Malignancy.E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast.Aberrant BLID expression is associated with breast cancer progression.Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.Progressive polarity loss and luminal collapse disrupt tissue organization in carcinoma.Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.[Diagnostic imaging of breast cancer : An update].Nomogram to predict the likelihood of upgrade of atypical ductal hyperplasia diagnosed on a core needle biopsy in mammographically detected lesions.Suspicious amorphous microcalcifications detected on full-field digital mammography: correlation with histopathology.
P2860
Q26773094-F10E7127-E28C-424D-BF8B-CE2CD62A9D05Q26851833-7C9E89D9-846B-4493-A099-611B9ED696C1Q30301033-74DD3B14-8486-4170-AF06-7FD163E7AA62Q33809773-FFA7E9A9-76DD-4EDB-9B20-759825B799A1Q33901920-F57F5CFA-7577-451B-83ED-0F62CCBDFF34Q35825853-7D34DADD-EB0B-4CBC-95C8-864DBDE0D7BAQ36265702-1E96A861-08DA-4716-BAB7-C15EDCE175ECQ36887123-47067F29-28FD-47CA-8FB8-F96D34C3726CQ37255480-3798922E-FF12-4037-9762-AAB2A4CB310EQ37805245-DE204D96-548F-42FE-A8A0-C8D91C4BF51AQ38663398-F6C1E6F5-F9DD-449A-841F-030DB2D6597AQ38696786-00F0AB79-7778-44BE-B488-B5C99EF39319Q38902230-5144C20B-299F-439F-A81F-217021077170Q39249755-9E12CBB8-C7D3-4CE6-B35D-BC3473B88D20Q40106617-F2E8634A-5687-4706-8D78-7B54C0299BF5Q42510239-4013EB22-8711-4D72-97EF-3F7973E154BDQ42514748-CEB83DAB-AF67-45B0-BEFA-D9041AA00BE2Q51102017-1F20A3A9-D550-4ED6-9EE5-879F959869DEQ53033455-50FDD88E-2601-4E98-BC38-18CB79C1F1E9Q53244069-CBF90765-28EE-4B75-8725-DD87FC586F9CQ55256768-E58E4C84-5E7D-4131-87F9-6B2A4362C44B
P2860
Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intraductal proliferative lesi ...... ed risk and molecular biology.
@en
Intraductal proliferative lesi ...... ed risk and molecular biology.
@nl
type
label
Intraductal proliferative lesi ...... ed risk and molecular biology.
@en
Intraductal proliferative lesi ...... ed risk and molecular biology.
@nl
prefLabel
Intraductal proliferative lesi ...... ed risk and molecular biology.
@en
Intraductal proliferative lesi ...... ed risk and molecular biology.
@nl
P2860
P1433
P1476
Intraductal proliferative lesi ...... ed risk and molecular biology.
@en
P2860
P2888
P356
10.1038/MODPATHOL.2010.56
P478
23 Suppl 2
P50
P577
2010-05-01T00:00:00Z